SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003; 68: 17811790.
  • 2
    Wooten JM. Adverse drug reactions: part I. South Med J 2010; 103: 10251028; quiz 1029.
  • 3
    Gell PGH, Coombs RRA. Clinical aspects of immunology. 2nd ed. Blackwell Scientific: Oxford; 1968.
  • 4
    Kuljanac I. Mechanisms of drug hypersensitivity reactions and the skin. Recent Pat Inflamm Allergy Drug Discov 2008; 2: 6471.
  • 5
    Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol 2010; 125: S126S137.
  • 6
    Carnahan RM, Moores KG. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: methods and lessons learned. Pharmacoepidemiol Drug Saf 2012; 21(S1): 8289.
  • 7
    Golden WE, Cleves MA, Heard JK, Brasher R, McKinney P, Johnston JC. Frequency and recognition of angiotensin-converting enzyme inhibitor-associated angioneurotic edema. Clin Perform Qual Health Care 1993; 1: 205207.
  • 8
    Macy E, Poon KYT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med 2009; 122: 778 e1e7.
  • 9
    Heckbert SR, Stryker WS, Coltin KL, Manson JE, Platt R. Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population. Am J Epidemiol 1990; 132: 336342.
  • 10
    Jackson LA, Carste BA, Malais D, Froeschle J. Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr Infect Dis J 2002; 21: 781786.
  • 11
    Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema. JAMA 1997; 278: 232233.
  • 12
    Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996; 60: 813.
  • 13
    Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 2008; 51: 16241630.
  • 14
    Johannes CB, Ziyadeh N, Seeger JD, Tucker E, Reiter C, Faich G. Incidence of allergic reactions associated with antibacterial use in a large, managed care organization. Drug Saf 2007; 30: 705713.
  • 15
    Nordstrom BL, Norman HS, Dube TJ, Wilcox MA, Walker AM. Identification of abacavir hypersensitivity reaction in health care claims data. Pharmacoepidemiol Drug Saf 2007; 16: 289296.
  • 16
    West SL, D'Aloisio AA, Ringel-Kulka T, Waller AE, Clayton Bordley W. Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000–2002). Pharmacoepidemiol Drug Saf 2007; 16: 12551267.
  • 17
    Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Int Med 2005; 165: 16371642.